학술논문
Activity of cefiderocol, ceftazidime-avibactam, and eravacycline against extended-spectrum cephalosporin-resistant Escherichia coli clinical isolates (2012–20017) in relation to phylogenetic background, sequence type 131 subclones, blaCTX-M genotype, and coresistance
Document Type
Article
Source
In Diagnostic Microbiology & Infectious Disease May 2021 100(1)
Subject
Language
ISSN
0732-8893